Millennium Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Millennium Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,027	Closed	-$20K	–	7576
2022 Q2	$20K	Buy	+1,027	New	+$25.7K	﹤0.01%	6486
2022 Q1	–	Sell	-554	Closed	-$20K	–	7597
2021 Q4	$20K	Buy	554 +32	+6%	+$1.69K	﹤0.01%	6602
2021 Q3	$39K	Buy	522 +7	+1%	+$497	﹤0.01%	6612
2021 Q2	$45K	Sell	515 -1,628	-76%	-$155K	﹤0.01%	6376
2021 Q1	$244K	Buy	+2,143	New	+$238K	﹤0.01%	5371
2018 Q3	–	Sell	-106	Closed	-$21K	–	4336
2018 Q2	$21K	Buy	+106	New	+$19.5K	﹤0.01%	3733
2017 Q2	–	Sell	-130	Closed	-$39K	–	3935
2017 Q1	$39K	Sell	130 -39	-23%	-$11.5K	﹤0.01%	3407
2016 Q4	$61K	Buy	+169	New	+$63K	﹤0.01%	3240
2016 Q2	–	Sell	-190	Closed	-$63K	–	3658
2016 Q1	$63K	Buy	+190	New	+$62.6K	﹤0.01%	3135
2015 Q2	–	Sell	-15	Closed	-$79K	–	3936
2015 Q1	$79K	Buy	+15	New	+$86K	﹤0.01%	3428

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Millennium Management's CSCI Position: Q3 2022 in Review

Millennium Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 1,027 shares — an estimated $20K sold.

Millennium Management first reported a position in CSCI in Q1 2015 and held it in 10 quarters. The position peaked at $244K in Q1 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Millennium Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 1,027 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $20K.
Millennium Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2015 and held it in 10 quarters.
Millennium Management's COSCIENS Biopharma Inc. Common Stock position peaked at $244K in Q1 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.